Is Postoperative Adjuvant Radioactive Iodine Ablation Therapy Always Necessary for Intermediate-Risk Papillary Thyroid Cancer Patients With Central Neck Metastasis?-Reference-Cited by-同舟云学术

Is Postoperative Adjuvant Radioactive Iodine Ablation Therapy Always Necessary for Intermediate-Risk Papillary Thyroid Cancer Patients With Central Neck Metastasis?

Published:2021-05-27 Issue:12 Volume:28 Page:7533-7544
ISSN:1068-9265
Container-title:Annals of Surgical Oncology
language:en
Short-container-title:Ann Surg Oncol

Author:

Han Kyujin,Noh Hae Min,Jeong Ha Min,Lim Young Chang

Funder

Konkuk University

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Surgery

Link

https://link.springer.com/content/pdf/10.1245/s10434-021-10164-1.pdf

Reference35 articles.

1. Sakorafas GH, Sampanis D, Safioleas M. Cervical lymph node dissection in papillary thyroid cancer: current trends, persisting controversies, and unclarified uncertainties. Surg Oncol. 2010;19:57–70.

2. DeSantis CE, Lin CC, Mariotto AB, et al. Cancer treatment and survivorship statistics. CA Cancer J Clin. 2014;64:252–71.

3. Grant CS. Recurrence of papillary thyroid cancer after optimized surgery. Gland Surg. 2015;4:52–62.

4. Liu FH, Kuo SF, Hsueh C, Chao TC, Lin JD. Postoperative recurrence of papillary thyroid carcinoma with lymph node metastasis. J Surg Oncol. 2015;112:149–54.

5. Carballo M, Quiros RM. To treat or not to treat: the role of adjuvant radioiodine therapy in thyroid cancer patients. J Oncol. 2012. https://doi.org/10.1155/2012/707156.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Controversies in the Management of Intermediate-Risk Differentiated Thyroid Cancer;Endocrine Practice;2024-09

2. Survival benefit of postoperative radioiodine therapy among patients with intermediate-risk differentiated thyroid carcinoma;Endocrine;2024-05-29

3. Survival benefit of postoperative radioiodine therapy among patients with intermediate-risk differentiated thyroid carcinoma;2024-03-06

4. Impact of radioiodine therapy on recurrence and survival outcomes in intermediate‐risk papillary thyroid carcinoma —A systematic review and meta‐analysis;Clinical Endocrinology;2023-12-04

5. Current practice in intermediate risk differentiated thyroid cancer – a review;Reviews in Endocrine and Metabolic Disorders;2023-11-23